450 filings
Page 22 of 23
8-K
h8hbow9e lv
1 Jul 14
Other Events
12:00am
8-K
vcpjzr5j ivmdeia1s3q
17 Jun 14
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
12:00am
10-Q
j94mo
13 May 14
Quarterly report
12:00am
8-K
kuhv148m
12 May 14
Recro Pharma Reports First Quarter 2014 Financial Results
12:00am
8-K
xu926 2flzj6zh
11 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
i6pg51s0tsteig
1 Apr 14
This presentation includes forward-looking statements within the meaning of Section
12:00am
S-8
46imys
21 Mar 14
Registration of securities for employees
12:00am
8-K
a0dl flxd46
13 Mar 14
Recro Pharma Announces New Board Members
12:00am
CT ORDER
nqekaaq40 hsk0
10 Mar 14
Confidential treatment order
12:00am
424B4
akojbrxk awph89ny
7 Mar 14
Prospectus supplement with pricing info
12:00am
EFFECT
jcta8qz8jk go
6 Mar 14
Notice of effectiveness
12:00am
S-1MEF
yovzo8cuzjvi v9fhkz
6 Mar 14
Registration of additional securities for an S-1
12:00am
8-A12B
4m1i04786ps449
4 Mar 14
Registration of securities on exchange
12:00am
CORRESP
30y xvg71
4 Mar 14
Correspondence with SEC
12:00am
CORRESP
1ph43m6w7btgt
4 Mar 14
Correspondence with SEC
12:00am
CORRESP
d5oc b2hwmyb
28 Feb 14
Correspondence with SEC
12:00am
UPLOAD
o590y guj8k
21 Feb 14
Letter from SEC
12:00am
FWP
ejg3fgjte
13 Feb 14
Free writing prospectus
12:00am